Related Experiment Video
Updated: Dec 20, 2025

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
Published on: April 28, 2013
Renal infarct in a COVID-19-positive kidney-pancreas transplant recipient
Jieqing J Xu1, Daniel Samaha2, Suhas Mondhe2
1Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, Ontario, Canada.
Insights
COVID-19 can increase blood clot risk, even after symptoms resolve. A kidney-pancreas transplant patient experienced a renal infarct 26 days post-COVID-19, suggesting a persistent hypercoagulable state.
Area of Science:
- Nephrology
- Transplant Surgery
- Infectious Diseases
Background:
- COVID-19 is linked to a higher risk of thromboembolic events.
- The duration and extent of the post-COVID-19 hypercoagulable state are not well understood.
- Solid organ transplant recipients may face unique risks.
Observation:
- A 46-year-old kidney-pancreas transplant recipient developed renal allograft infarction.
- The patient had no prior history of thromboembolism.
- The infarction occurred 26 days after a COVID-19 diagnosis, while the patient was symptom-free and tested negative for SARS-CoV-2.
Findings:
- This case report highlights the potential for a persistent hypercoagulable state following COVID-19 infection.
- Renal allograft infarction can occur in transplant recipients after COVID-19 recovery.
Implications:
- Further research is needed to understand the long-term thrombotic risks associated with COVID-19 in transplant patients.
- Guidelines for thromboprophylaxis duration and indications in solid organ transplant recipients post-COVID-19 require further investigation.
Abstract:
The novel coronavirus disease 2019 (COVID-19) is associated with increased risk of thromboembolic events, but the extent and duration of this hypercoagulable state remain unknown. We describe the first case report of renal allograft infarction in a 46-year-old kidney-pancreas transplant recipient with no prior history of thromboembolism, who presented 26 days after diagnosis of COVID-19. At the time of renal infarct, he was COVID-19 symptom free and repeat test for SARS-CoV-2 was negative. This case report suggests that a hypercoagulable state may persist even after resolution of COVID-19. Further studies are required to determine thromboprophylaxis indications and duration in solid organ transplant recipients with COVID-19.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology

